Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap?
- DOI
- 10.1016/j.lungcan.2020.12.022
- Published
- 2021 Feb
- Container
- Lung cancer (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.lungcan.2020.12.022,
title = {Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap?},
author = {Gendarme S and Matton L and Antoine M and Kerrou K and Ruppert AM and Epaud C and Cadranel J and Fallet V},
year = {2021},
journal = {Lung cancer (Amsterdam, Netherlands)},
doi = {10.1016/j.lungcan.2020.12.022},
url = {https://doi.org/10.1016/j.lungcan.2020.12.022}
}RIS
TY - JOUR TI - Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap? AU - Gendarme S AU - Matton L AU - Antoine M AU - Kerrou K AU - Ruppert AM AU - Epaud C AU - Cadranel J AU - Fallet V PY - 2021 JO - Lung cancer (Amsterdam, Netherlands) DO - 10.1016/j.lungcan.2020.12.022 UR - https://doi.org/10.1016/j.lungcan.2020.12.022 ER -
APA
S, G., L, M., M, A., K, K., AM, R., C, E., J, C., & V, F. (2021). Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma: A therapeutic trap?. Lung cancer (Amsterdam, Netherlands). https://doi.org/10.1016/j.lungcan.2020.12.022
Source records
- pubmed · retrieved 2026-09-25T06:44:49.656Z